FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma
Smaller Ultrasound-Guided Biopsy Needle Safe, Effective, For Suspected Breast Cancer
Gleevec First Pediatric Cancer Approval By FDA In 13 Years
FDA Clears Rapid Test For Aspergillus Infection
New Agent Targets Glioma Tumor Cells Prior To Surgery
Fruits, Vegetables Protective Against Cancer, IARC Says
Heavy Smokers And Drinkers Have Different Brain Chemistry
NCI-Approved Clinical Trials
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- Most Favored Nation drug pricing could put China on top
- NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
- Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line









